New Alzheimer's drug J4 enters first human safety tests

NCT ID NCT06938763

First seen Jan 08, 2026 · Last updated Apr 28, 2026 · Updated 18 times

Summary

This early-stage trial tests whether a new oral drug called J4 is safe for people. It involves 76 healthy adults aged 18 to 64. Researchers will give single and multiple doses to see how the body handles the drug and if any side effects occur. This study does not treat Alzheimer's directly but gathers important safety information for future research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Taipei Medical University Hospital

    RECRUITING

    Taipei, 110, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.